Subfoveal and juxtafoveal Subretinal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome: Visual Prognosis

R. Joseph Olk, Dean B. Burgess, Patricia A. McCormick

Research output: Contribution to journalArticle

66 Scopus citations

Abstract

The visual prognosis of 148 eyes in patients with an active subfoveal or juxtafoveal subretinal neovascular membrane (SRNVM) in the presumed ocular histoplasmosis syndrome (PONS) was reviewed. Average follow-up was 39 months. One hundred twenty of 148 eyes (81.1%) had a final visual acuity worse than 20/40. One hundred three of 148 eyes (69.6%) had a final visual acuity equal to or worse than 20/200. Systemic and/or periocular steroids had no effect on final visual outcome. Factors affecting final visual outcome are described and prognosis in the fellow eye is discussed.

Original languageEnglish
Pages (from-to)1592-1602
Number of pages11
JournalOphthalmology
Volume91
Issue number12
DOIs
StatePublished - Jan 1 1984

Keywords

  • fellow eye prognosis
  • juxtafoveal
  • presumed ocular histoplasmosis syndrome
  • subfoveal
  • subretinal neovascular membranes
  • visual prognosis

Fingerprint Dive into the research topics of 'Subfoveal and juxtafoveal Subretinal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome: Visual Prognosis'. Together they form a unique fingerprint.

  • Cite this